ES8601869A1 - Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro - Google Patents
Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puroInfo
- Publication number
- ES8601869A1 ES8601869A1 ES534695A ES534695A ES8601869A1 ES 8601869 A1 ES8601869 A1 ES 8601869A1 ES 534695 A ES534695 A ES 534695A ES 534695 A ES534695 A ES 534695A ES 8601869 A1 ES8601869 A1 ES 8601869A1
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- cefuroxyme
- acetoxyethylene
- ester
- prepare
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 229950003588 axetil Drugs 0.000 abstract 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical compound CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UN PROCEDIMIENTO PARA OBTENER CEFUROXIMA-AXETIL CRISTALINA Y PURISIMA. COMPRENDE CRISTALIZAR CEFUROXIMA-AXETIL A PARTIR DE UNA DISOLUCION DE LA MISMA EN UN DISOLVENTE ORGANICO O ACUOSO, O EN UNA MEZCLA DE AMBOS, Y LUEGO SECAR Y AISLAR EL PRODUCTO. LOS DISOLVENTES PREFERIDOS SON ACETATOS DE ALQUILO MEZCLADOS CON ETERES O CON HIDROCARBUROS ALIFATICOS O AROMATICOS. CUANTO MAYOR SEA EL RENDIMIENTO DE LA CRISTALIZACION, EL PRODUCTO CONTENDRA UNA RELACION ESTEQUIOMETRICA DE ISOMEROS R:S MAS PROXIMA A 1:1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838320521A GB8320521D0 (en) | 1983-07-29 | 1983-07-29 | Chemical process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8601869A1 true ES8601869A1 (es) | 1985-11-01 |
| ES534695A0 ES534695A0 (es) | 1985-11-01 |
Family
ID=10546505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES534695A Granted ES534695A0 (es) | 1983-07-29 | 1984-07-27 | Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPH0613526B2 (es) |
| KR (1) | KR910008377B1 (es) |
| AT (1) | AT392470B (es) |
| AU (2) | AU582121B2 (es) |
| BE (1) | BE900241A (es) |
| CA (1) | CA1265511A (es) |
| CH (1) | CH662121A5 (es) |
| DE (1) | DE3427828A1 (es) |
| DK (1) | DK165505C (es) |
| ES (1) | ES534695A0 (es) |
| FI (1) | FI76808C (es) |
| FR (1) | FR2549837B1 (es) |
| GB (2) | GB8320521D0 (es) |
| IE (1) | IE57726B1 (es) |
| IL (1) | IL72536A (es) |
| NL (1) | NL8402372A (es) |
| NO (1) | NO167292C (es) |
| NZ (1) | NZ209046A (es) |
| PT (1) | PT78985B (es) |
| SE (1) | SE463263B (es) |
| ZA (1) | ZA845830B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8400024D0 (en) * | 1984-01-03 | 1984-02-08 | Glaxo Group Ltd | Cephalosporin antibiotics |
| GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
| IT1277426B1 (it) * | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | Forma cristallina biodisponibile del cefuroxima axetil |
| CN1111537C (zh) * | 1997-05-15 | 2003-06-18 | 第一制糖株式会社 | 高纯晶形头孢呋辛1-乙酰氧乙酯的制备方法 |
| KR100228264B1 (ko) * | 1997-08-02 | 1999-11-01 | 김선진 | 결정형 세푸록심 악세틸의 제조방법 |
| CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| IN186539B (es) * | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd | |
| EP0937727B1 (de) * | 1998-02-20 | 2002-01-30 | Fako Ilaclari A.S. | Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil |
| IN190849B (es) | 2000-07-17 | 2003-08-23 | Ranbaxy Lab Ltd | |
| AT411996B (de) | 2000-09-11 | 2004-08-26 | Sandoz Ag | Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes |
| ITMI20011763A1 (it) * | 2001-08-10 | 2003-02-10 | Antibioticos Spa | Processo di preparazione di cefuroxime axelite ad elevata purezza |
| ITMI20011925A1 (it) * | 2001-09-14 | 2003-03-14 | Antibioticos Spa | Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino |
| TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
| DE102005019458A1 (de) * | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
| CN118561870A (zh) * | 2024-05-15 | 2024-08-30 | 广东立国制药有限公司 | 一种制备头孢呋辛酸的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| CA1094545A (en) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| GB1598568A (en) * | 1977-04-19 | 1981-09-23 | Glaxo Lab Ltd | Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid |
| JPS577485A (en) * | 1980-06-13 | 1982-01-14 | Takeda Chem Ind Ltd | Cephalosporin |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8400024D0 (en) * | 1984-01-03 | 1984-02-08 | Glaxo Group Ltd | Cephalosporin antibiotics |
-
1983
- 1983-07-29 GB GB838320521A patent/GB8320521D0/en active Pending
-
1984
- 1984-07-27 NL NL8402372A patent/NL8402372A/nl not_active Application Discontinuation
- 1984-07-27 ZA ZA845830A patent/ZA845830B/xx unknown
- 1984-07-27 NO NO843055A patent/NO167292C/no not_active IP Right Cessation
- 1984-07-27 JP JP59155694A patent/JPH0613526B2/ja not_active Expired - Lifetime
- 1984-07-27 DE DE19843427828 patent/DE3427828A1/de not_active Ceased
- 1984-07-27 GB GB08419202A patent/GB2145409B/en not_active Expired
- 1984-07-27 KR KR1019840004465A patent/KR910008377B1/ko not_active Expired
- 1984-07-27 AT AT2444/84A patent/AT392470B/de not_active IP Right Cessation
- 1984-07-27 PT PT78985A patent/PT78985B/pt unknown
- 1984-07-27 ES ES534695A patent/ES534695A0/es active Granted
- 1984-07-27 FI FI843011A patent/FI76808C/fi not_active IP Right Cessation
- 1984-07-27 AU AU31256/84A patent/AU582121B2/en not_active Ceased
- 1984-07-27 FR FR8412011A patent/FR2549837B1/fr not_active Expired
- 1984-07-27 DK DK366684A patent/DK165505C/da not_active IP Right Cessation
- 1984-07-27 SE SE8403897A patent/SE463263B/sv not_active IP Right Cessation
- 1984-07-27 CH CH3672/84A patent/CH662121A5/de not_active IP Right Cessation
- 1984-07-27 BE BE0/213398A patent/BE900241A/fr not_active IP Right Cessation
- 1984-07-27 CA CA000459929A patent/CA1265511A/en not_active Expired - Fee Related
- 1984-07-27 IE IE1938/84A patent/IE57726B1/en not_active IP Right Cessation
- 1984-07-29 IL IL72536A patent/IL72536A/xx not_active IP Right Cessation
- 1984-07-30 NZ NZ209046A patent/NZ209046A/en unknown
-
1989
- 1989-06-16 AU AU36601/89A patent/AU634965B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8601869A1 (es) | Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro | |
| AU512448B2 (en) | The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid | |
| BE854197A (fr) | Nouveaux esters de l'acide malonique utilisables par la stabilisation de matiere organiques | |
| ES2070536T3 (es) | Saliciloil-carnitina y procedimiento para su preparacion. | |
| ES2051731T3 (es) | Un procedimiento para preparar antibioticos macrolidos y su uso. | |
| JPS52250A (en) | Process for preparation of 8-exo-hydroxy-endo-tricyclo-(5,2,2,02,6) ) unde cane | |
| JPS52109545A (en) | Preparation of aqueous polyolefin dispersions | |
| ES8400089A1 (es) | Procedimiento para preparar derivados de fenantreno. | |
| JPS5287157A (en) | Preparation of provitamin d compounds | |
| JPS5441664A (en) | Polishing method for indium phosphorus crystal | |
| JPS5283750A (en) | Crystals of 5-amino-4-imidazol-carboxyamide | |
| JPS5268116A (en) | Preparation of alkoxyalkylidene compounds | |
| JPS51143606A (en) | Process for preparation of 1,3- propanediols | |
| JPS5326823A (en) | Preparation of 6,13-dihydroquinacridone | |
| JPS52151148A (en) | Preparation of substituted cyclopropanecarboxylic acid derivatives | |
| JPS5280384A (en) | Preparation of graft polymers | |
| JPS5318549A (en) | Preparation of optical active compounds by irradiation | |
| JPS51136643A (en) | Process for preparation of aromatic ester derivatives | |
| JPS5211169A (en) | Pure water producing apparatus | |
| JPS5289684A (en) | Preparation of triesters of isocyanuric acid | |
| ES2081520T3 (es) | Procedimiento de depuracion de compuestos de diaminodifenil. | |
| JPS5268229A (en) | Preparation of bisoxazolyl ethylene compound | |
| JPS5265257A (en) | Synthesis of tricyclo 6,2,1,0 undecane | |
| JPS5287156A (en) | Isolation of provitamin d compounds | |
| JPS5214758A (en) | Preparation of carboxyl-containing derivatives |